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Abstract
Accumulating evidence suggests that tumor-initiating stem cells or cancer stem cells (CSCs) possibly originating from
normal stem cells may be the root cause of certain malignancies. How stem cell homeostasis is impaired in tumor tissues is
not well understood, although certain tumor suppressors have been implicated. In this study, we use the Drosophila neural
stem cells (NSCs) called neuroblasts as a model to study this process. Loss-of-function of Numb, a key cell fate determinant
with well-conserved mammalian counterparts, leads to the formation of ectopic neuroblasts and a tumor phenotype in the
larval brain. Overexpression of the Drosophila tumor suppressor p53 (dp53) was able to suppress ectopic neuroblast
formation caused by numb loss-of-function. This occurred in a non-apoptotic manner and was independent of Dacapo, the
fly counterpart of the well-characterized mammalian p53 target p21 involved in cellular senescence. The observation that
dp53 affected Edu incorporation into neuroblasts led us to test the hypothesis that dp53 acts through regulation of factors
involved in cell cycle progression. Our results show that the inhibitory effect of dp53 on ectopic neuroblast formation was
mediated largely through its regulation of Cyclin E (Cyc E). Overexpression of Cyc E was able to abrogate dp539s ability to
rescue numb loss-of-function phenotypes. Increasing Cyc E levels by attenuating Archipelago (Ago), a recently identified
transcriptional target of dp53 and a negative regulator of Cyc E, had similar effects. Conversely, reducing Cyc E activity by
overexpressing Ago blocked ectopic neuroblast formation in numb mutant. Our results reveal an intimate connection
between cell cycle progression and NSC self-renewal vs. differentiation control, and indicate that p53-mediated regulation
of ectopic NSC self-renewal through the Ago/Cyc E axis becomes particularly important when NSC homeostasis is perturbed
as in numb loss-of-function condition. This has important clinical implications.
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Introduction
Brain tumors constitute a deadly malignancy that affects a large
human population, especially the children. Recently, it was
demonstrated that the presence of tumor-initiating cells with
features characteristic of normal tissue stem cells might be the root
cause of cancer and account for the relapse of cancer after surgery
[1,2,3]. It is therefore critically important to understand the origin
of these brain cancer stem cells (CSCs) and the molecular and
cellular mechanisms by which their aberrant behaviors contribute
to the pathogenesis of brain tumors.
Recent studies on Drosophila neuroblasts have provided impor-
tant insights into the biology of CSCs. Drosophila neuroblasts
display extensive stem cell-like features. They divide asymmetri-
cally to generate one daughter cell with renewed NSC fate and the
other committed to differentiation. A growing number of factors,
many of which are asymmetrically segregated, have been
identified to establish NSC fate and maintain their homeostasis
in Drosophila. They participate in diverse cellular processes
including coordination of cell cycle with cell fate determination,
connection of cell polarity with NSC self-renewal and differenti-
ation, or modulation of transcriptional or translational regulatory
networks to confer distinct daughter cell fates (for recent reviews
see [4,5,6]). Loss-of-function of factors that are inherited
preferentially by the differentiating daughter cell tends to result
in dramatic increase of NSCs and consequently tumor-like
overgrowth [7,8]. Among these factors, Numb is the first identified
cell fate determinant that limits neuroblast self-renewal by acting
as a tumor suppressor. The revelation of mammalian Numb in
tumorigenesis highlights the relevance of studies of Drosophila
neuroblast behavior to cancer biology [9]. Numb has been
intensively studied for molecular and cellular mechanisms
underlying its regulation [10,11,12]. The function of Numb is
regulated at two levels: its asymmetric localization and its activity
as an antagonist of Notch signaling [11,13,14]. Recently, Polo
kinase-mediated phosphorylation was shown to modulate Numb
activity in Drosophila NSCs [15]. Overexpression of a mutant form
of Numb mimicking the hyper-phosphorylated form (Numb-
TS4D) interfered with the antagonistic effect of endogenous Numb
on Notch signaling and resulted in ectopic neuroblasts, similar to
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28098that seen in numb mutant. In this study, we have used the Drosophila
numb null mutant and the Numb-TS4D overexpression back-
grounds to model brain tumor formation.
As NSCs divide asymmetrically to generate sibling cells with
distinct fates and proliferation potentials, it has long been
hypothesized that there exists intricate interplay between the cell
cycle and the asymmetric cell division machineries. Indeed, partial
attenuation of Cdc2 activity without blocking mitosis led to failures
of asymmetric localization of cell fate determinants and the
acquisition of distinct sibling cell fates during embryonic NSC
divisions [16]. This result suggested that Cdc2 serves as a
molecular connection between the cell cycle and asymmetric
protein localization machineries. Recently, cell cycle genes,
especially those involved in the control of G1/S transition, have
been implicated in regulating the self-renewal, differentiation, and
survival of NSCs and/or neural progenitors in mammals. For
example, members of the Cyclin-dependent kinase inhibitor
(CDKI) family such as p27 and p21, which promote cell cycle
exit into a G0 state, have been demonstrated to negatively regulate
the proliferation potential of NSCs and/or neural progenitors
during embryonic or adult neurogenesis [17,18,19]. In addition,
the retinoblastoma (Rb) protein, an inhibitor of G1 to S phase
(G1-S) transition, inhibits neural progenitor self-renewal by
repressing the expression of Hes1, one of the Notch pathway
targets [20,21]. Thus factors that prevent S phase entry can restrict
the self-renewal capacity of NSCs and/or neural progenitors.
Factors that promote G1-S transition may also influence NSC self-
renewal. Cyc E is one such factor that activates CDK2 through
direct binding [22,23,24,25]. Either ectopic expression of Cyc E or
inhibition of CDKI facilitated reprogramming of terminally
differentiated cells into induced pluripotent stem cells (iPSCs).
Conversely, extension of the G1 phase in human embryonic stem
cells (hESCs) impairs their pluripotency and causes precocious
differentiation [26]. These results suggest that having a shorter G1
phase of the cell cycle may be essential for maintaining stem cell
pluripotency. How the cell cycle properties of stem cells are
regulated, however, is not well understood.
The p53 tumor suppressor plays a prominent role in tissue
homeostasis by controlling multiple cellular processes through
diverse effectors [27,28]. Inactivation of p53 function is associated
with brain tumors, especially glioblastoma in humans
[29,30,31,32]. Mice lacking p53 have increased number of
proliferating adult neural stem cells [33,34]. Moreover, mice
devoid of both p53 and PTEN exhibit an acute-onset phenotype of
glioblastoma with NSCs showing enhanced self-renewal capacity
[35], supporting that p53 plays an important role in the regulation
of NSC homeostasis. However, the mechanisms of action of p53
and whether p53 exerts its pathophysiological role in brain
tumorigenesis by acting on tumor mass cells in general or just a
subset of tumor-initiating stem cell-like cells has not been clearly
addressed. In mammals, a link between p53 and Numb has been
established, with Numb promoting p53 stability through inhibition
of the E3 ubiquitin ligase MDM2 [36]. Whether this relationship is
conserved in Drosophila is not certain, since a clear fly homologue of
MDM2 is yet to be identified. In this study, we tested whether p53
functionally interacts with Numb in regulating NSC homeostasis.
We demonstrate that dp53 is able to prevent ectopic NSC
formation in numb mutant or Numb-TS4D overexpression
backgrounds, in an apparently apoptosis-independent manner.
We provide evidence that the inhibitory effect of dp53 is mediated
by Cyc E. Furthermore, we show that dp53 likely regulates Cyc E
through its known transcriptional target Archipelago (Ago), which
is recently shown to be a negative regulator of Cyc E [37,38,39].
These results thus establish a functional link between cell cycle
progression and NSC self-renewal vs. differentiation choice,
identify from the multitude of p539s cellular functions one
particular mode of p53 action that is critical for regulating stem
cell behavior, and suggest new ways to manipulate NSC behavior
for research or therapeutic purposes.
Results
Overexpression of dp53 suppresses the ectopic
neuroblast formation phenotypes in numb mutant or
Numb-TS4D overexpression backgrounds
To test whether dp53 is capable of exerting a tumor suppressor
function in NSC homeostasis control through functional interac-
tion with Numb, we first overexpressed wild type dp53 (dp53-WT)
in numb null mutant and examined the effect of dp53 on the
formation of excess neuroblasts caused by Numb loss-of-function.
Interestingly, enforced expression of dp53 in numb mutant
effectively inhibited ectopic neuroblast formation (Figure 1B–C),
indicating that dp53 is able to restrain uncontrolled neuroblast
self-renewal. Numb-TS4D, a phospho-mimetic form of Numb in
which 5 putative Polo phosphorylation sites have been changed to
negatively charged amino acids, acted in a dominant-negative
fashion and promoted ectopic neuroblast formation as well when
overexpressed [15]. To test whether enforced expression of dp53 is
able to suppress the ectopic neuroblast formation induced by
Numb-TS4D, we co-expressed dp53-WT with Numb-TS4D in
neuroblasts using the 1407-Gal4 driver. Overexpression of dp53-
WT almost completely rescued the ectopic neuroblast formation
phenotype in Numb-TS4D background (Figure 1D–F). In
contrast, a transgene expressing dp53-H159N, a mutant form of
dp53 that lacks transactivation activity, did not suppress ectopic
neuroblast formation induced by Numb-TS4D (Figure 1F),
indicating that the transcriptional transactivation activity of dp53
is required for its ability to restrain the formation of ectopic
neuroblasts.
To test whether endogenous dp53 normally plays a role in
regulating ectopic neuroblast formation in numb loss-of-function
background, we tested the effect of complete loss of dp53 on a mild
ectopic neuroblast formation phenotype induced by a Numb-S2D
transgene [15], which represents a weak dominant-negative form
of Numb (Figure S1). We did not observe obvious modification by
loss of dp53 function on the ectopic neuroblast formation induced
by inactivation of Numb. It is possible that the physiological
function of dp53 would only manifest itself under specific
conditions (see discussion).
The rescuing effect of dp53 overexpression on excess
neuroblast formation caused by Numb loss-of-function is
not due to induction of neuroblast apoptosis
p53 is known to initiate apoptosis under stress conditions such as
radiation-induced DNA damage [40,41,42,43], or when overex-
pressed in post-mitotic neurons such as photoreceptors [43,44]. To
test whether the rescuing effect of dp53 is attributable to its
induction of apoptosis in neuroblasts, we performed two
experiments. First, we used TUNEL staining to detect the
presence of apoptotic cells in dp53-overexpressing animals. We
did observe that the overall number of TUNEL-positive nucleus
was increased in dp53-overexpressing larval brains compared to
control wild type brains. However, we rarely observed neuroblasts
that were TUNEL-positive (Figure 2A), indicating that overex-
pression of dp53 did not induce neuroblast apoptosis under the
conditions we used, and that most of the TUNEL-positive cells in
dp53-overexpressing larval brain were post-mitotic neurons or
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backgrounds. (A–C) Inhibition of ectopic neuroblast formation in numb mutant by dp53. The UAS-dp53-WT transgenes were introduced into
numb
15 null mutant MARCM clones marked with GFP (green). Type II neuroblasts were identified as Miranda-positive (Mira
+, red) and Asense-negative
(Ase
-, blue) cells with a diameter of around 10 mm and were labeled with asterisks. The smaller Mira
+ cells are intermediate progenitors. Note that the
clone in B and B’ is of bigger size than that in A and C as indicated by the scale bars. The number of type II neuroblasts in dp53-expressing numb
mutant (C) is much less than that of numb
15 mutant alone (B). The genotypes of each panel are FRT40A (A), FRT40A, numb
15 (B), and FRT40A, numb
15,
UAS-dp53-WT; 1407-Gal4 (C), respectively. (D–F) dp53-WT (E), but not dp53-H159N (F), inhibits the ectopic neuroblast formation phenotype induced
by Numb-TS4D. The corresponding transgenes were overexpressed in neuroblasts using the 1407-Gal4 driver. Neuroblasts are identified by Mira
immunostaining (green). Quantification of neuroblast number is shown in F. Eight animals from each genotype were analyzed. Scale bars, 10 mm.
doi:10.1371/journal.pone.0028098.g001
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apoptosis, was known to be able to block dp53-induced apoptosis
in the Drosophila eye imaginal disc [43]. We found that
overexpression of p35 in neuroblasts by itself did not affect
neuroblast number (Figure S2). Next we co-expressed p35 with
dp53-WT in Numb-TS4D overexpression background and
examined whether dp53 was still able to block the ectopic
neuroblast formation effect of Numb-TS4D, when apoptosis was
blocked by p35. We found that in the presence of p35, dp53 still
effectively suppressed excess neuroblast formation induced by
Numb-TS4D, to a similar extent as when p35 was not introduced
(Figure 2B–2D). This result supports that apoptosis is unlikely to
account for the rescuing effect of dp53 on the ectopic neuroblast
formation induced by Numb loss-of-function. Consistently, dp53
and p35 co-expression also failed to block the ability of dp53 to
suppress excess neuroblast formation in numb mutant MARCM
clones (Figure 2E–F). Together, these results suggest that apoptosis
is unlikely to be the main mechanism by which dp53 exerts its
effect in restraining ectopic neuroblast formation when Numb
function is compromised.
The rescuing effect of dp53 on ectopic neuroblast
formation caused by Numb loss-of-function is
independent of Dacapo, the only Drosophila homologue
of p21/p27
p53 acts as a tumor suppressor by regulating multiple targets,
including those involved in cell cycle progression [28]. Among the
diverse downstream effectors of mammalian p53 that have been
implicated in controlling cell cycle progression, p21 is a primary
target that is significantly induced by p53 and acts as a CDKI to
stall cell proliferation and induce senescence, and it has been
implicated in the regulation of NSC self-renewal [45] and in
mediating the effect of p53 on the reprogramming of somatic cells
to iPSCs [46,47]. The Drosophila homologue of mammalian p21/
p27, dacapo (dap), also plays an important role in cell cycle
progression [48,49], although it does not appear to be induced by
dp53 [40]. However, a functional interaction between dp53 and
Dap/p21 has been observed in the fly eye [44]. To test whether
the rescuing effect of dp53 observed above might be related to
Dap-mediated cell cycle arrest, we co-expressed dp53 and Numb-
TS4D in dap mutant background. dap mutant alone did not alter
neuroblast number in an otherwise wild type background (Figure
S3). Importantly, we found that the absence of dap did not
attenuate the ability of dp53 in suppressing the formation of
ectopic neuroblasts induced by Numb-TS4D, suggesting that Dap
is unlikely to be involved in the regulation of neuroblast
homeostasis by dp53 in this background (Figure 3).
Overexpression of Cyc E is able to reverse the rescuing
effect of dp53 on excess neuroblast formation caused by
Numb loss-of-function
We further explored the mechanism by which dp53 exerts its
effects on neuroblast homeostasis. Extensive studies on p53
function in tumor suppression in various settings suggest that it
acts through three major mechanisms: 1) Apoptosis, 2) Promotion
of senescence through p21-related CDKIs, 3) Cell cycle check
point control [50]. Our results have so far ruled out apoptosis and
p21-related senescence as possible mechanisms. To test whether
cell cycle control is involved, we conducted 5-Ethynyl-20-
deoxyuridine (Edu)-labeling experiments using numb mutant with
or without dp53 co-expression. Edu can be incorporated into
newly synthesized DNA during S phase and therefore is often used
as an indicator of proliferation capacity. We found that the
number of Edu-positive cells was drastically decreased upon
overexpression of dp53 in numb mutant (Figure 4A and 4B),
indicating that dp53 is likely to affect G1-S transition. Cyc E is one
of the key cell cycle regulators involved in G1-S transition and is
Figure 2. The inhibitory effect of dp53 on ectopic neuroblast
formation is not due to neuroblast apoptosis. (A) Larval brains
co-expressing Numb-TS4D and dp53-WT were analyzed for TUNEL (red)
and Mira immunostaining (green). Note that TUNEL
+ signals were not
found in neuroblasts. (B–D) p35 is unable to block the rescuing effect of
dp53 on ectopic neuroblast formation in Numb-TS4D overexpression
background. The corresponding transgenes were overexpressed in
neuroblasts using the 1407-Gal4 driver. Quantification of neuroblast
number is shown in D.( E, F) p35 is unable to block the rescuing effect
of dp53 on ectopic neuroblast formation in numb mutant. dp53 alone
(E, E’) or dp53 and p35 together (F, F’) were overexpressed in numb
mutant MARCM clones marked with GFP (green). Canonical neuroblasts
identified as Mira
+ cells (red) with a diameter of around 10 mm are
labeled with asterisks. The smaller Mira
+ cells are intermediate
progenitors. The numbers of neuroblasts in these two genotypic
backgrounds are 2.6760.52 (E) and 2.8360.41 (F), which are not
statistically significant. The genotypes of each panel are FRT40A,
numb
15, UAS-dp53-WT (E) and FRT40A, numb
15, UAS-dp53-WT; UAS-p35
(F). Six animals from each genotype were analysed. Scale bars, 10 mm.
doi:10.1371/journal.pone.0028098.g002
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Cyc E protein level was reduced upon dp53 overexpression (Figure
S4). This prompted us to hypothesize that the rescuing effect of
dp53 on numb mutant might be caused by a negative regulation of
Cyc E by dp53. To test this hypothesis, we co-expressed Cyc E and
dp53 transgenes in numb mutant. Interestingly, we observed a
significant increase of ectopic neuroblasts upon co-expression of
Cyc E with dp53 in numb mutant, compared to overexpression of
dp53 alone in numb mutant (Figure 4C–D), suggesting that
exogenously provided Cyc E is able to block the inhibitory effect
of dp53 on ectopic neuroblast formation in numb mutant. Of note,
overexpression of Cyc E in a wild type background did not change
neuroblast number (Figure S5A). This suggests that Cyc E is
necessary but not sufficient for the induction of ectopic
neuroblasts, implying the involvement of other yet to be identified
components of the neuroblast self-renewal program in ectopic
neuroblast formation.
Ago acts downstream of dp53 to link dp53 with Cyc E in
neuroblast homeostasis regulation
We also tried to test whether loss of Cyc E is sufficient to prevent
ectopic neuroblast formation induced by Numb loss-of-function.
Using two independent Cyc E RNAi lines, we were unable to
observe discernable effect on the Numb loss-of-function pheno-
types, presumably due to their inadequate knockdown of Cyc E
expression. Due to the close proximity of numb and cyc E genes in
the Drosophila genome, we have so far not been able to generate a
numb cyc E double mutant to examine the relationship between
Numb and Cyc E through a mutational approach. Therefore, we
used another approach to attenuating Cyc E function. Ago is
transcriptionally induced by dp53 in response to mitochondrial
metabolic stress, and it has been well established that Ago can act
as a negative regulator of Cyc E protein levels in vivo by promoting
Cyc E degradation through the ubiquitin proteasome system
[37,38,39,51]. Such negative regulation of Cyc E by Ago appeared
to be present in the Drosophila larval brain (Figure S6). To explore
the relationship between Cyc E and dp53 in the regulation of
neuroblast homeostasis, we altered endogenous Cyc E levels by
genetic manipulation of Ago activity. First, we tested whether 50%
reduction of ago gene dosage might have any effect on the ectopic
neuroblast formation induced by Numb-TS4D. No effect was
detected (Figure S7), presumably because 50% reduction of Ago
function is not sufficient to induce Cyc E level above certain
threshold level. Next we tried manipulating Ago function using
AgoDF. Overexpression of AgoDF, a dominant-negative form of
Ago lacking the F-box domain [38], is expected to increase Cyc E
function by interfering with Ago-mediated Cyc E ubiquitination
and degradation. Although overexpression of AgoDF alone had no
effect on neuroblast number, when AgoDF was co-expressed with
dp53 in numb mutant, there was a significant increase of ectopic
neuroblasts compared to numb mutant overexpressing dp53 alone
(Figure 4E–E), suggesting that elevation of Cyc E level through
AgoDF expression is also able to attenuate the rescuing effect of
dp53.
Although overexpression of Cyc E was not sufficient to induce
ectopic neuroblast formation in a wild type background, it is still
possible that elevated Cyc E level is required for the formation of
ectopic neuroblasts in numb mutant or Numb-TS4D overexpres-
sion background. To test this possibility, we examined whether
overexpression of Ago-WT, which is capable of promoting Cyc E
ubiquitination and degradation, would be able to rescue the
ectopic neuroblast formation phenotype in numb mutant. Indeed,
we found that while overexpression of Ago-WT alone in an
otherwise wild type background had no effect on neuroblast
number (Figure S5B), it reduced the number of ectopic neuroblasts
by approximately 36% in numb mutant (Figure 4F–G), suggesting
that Ago-WT can restrain ectopic neuroblast formation in numb
mutant, presumably through downregulating Cyc E function.
To further assess the connection of Ago with dp53 and Numb,
we performed more experiments using Numb and p53 overex-
pression conditions. Our results showed that either AgoDF or Cyc
E overexpression could partially suppress the neuroblast-loss
phenotype induced by p53 overexpression, consistent with Ago
and Cyc E being important downstream mediators of p53 function
in neuroblast homeostasis regulation (Figure S8). In contrast,
AgoDF or Cyc E overexpression failed to rescue the type II
neuroblast-loss phenotype induced by Numb overexpression
(Figure S8). It is possible that Numb overexpression causes
neuroblast loss through a mechanism distinct from p53 overex-
pression; alternatively, AgoDF or Cyc E overexpression may be
less effective in preventing the overexpression effect of Numb
simply because they act further away from Numb than from p53 in
the genetic pathway.
In addition to Cyc E, dMyc has also been shown to be a
subjected to Ago-mediated degradation [52]. dMyc is potently
pro-proliferative and plays important roles in cancer cell
proliferation and stem cell maintenance (including iPS cells), and
thus makes a reasonable candidate for mediating p53 function in
regulating ectopic neuroblast formation in numb mutant. Surpris-
ingly, unlike Cyc E, dMyc level did not appear to be affected by
dp53 overexpression (Figure S9). Thus, while we do not exclude a
possible role of dMyc in the ectopic NB formation process, it does
appear that Cyc E and dMyc are differentially regulated by the
p53/Ago pathway in the ectopic NB self-renewal process.
Figure 3. The inhibitory effect of dp53 on ectopic neuroblast
formation is independent of dap function. (A, A’) Wild type
neuroblast MARCM clones co-expressing Numb-TS4D and dp53. (B, B’)
dap mutant neuroblast MARCM clones co-expressing Numb-TS4D and
dp53. Clones were marked with GFP (green). The presence of the
Numb-TS4D transgenes is shown in blue. Neuroblasts (red) are
identified as Dpn
+ cells and marked with asterisks. The numbers of
neuroblasts in these two genotypic backgrounds are 2.8860.35 (A) and
2.7560.50 (B), which are not statistically significant. The genotypes are
FRT42D; UAS-dp53-WT, UAS-Numb-TS4D (A) and FRT42D, dap; UAS-dp53-
WT, UAS-Numb-TS4D (B). Eight animals from each genotype were
analyzed. Scale bars, 10 mm.
doi:10.1371/journal.pone.0028098.g003
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In this study we use the Drosophila neuroblast as a model system to
investigate a possible role of the tumor suppressor dp53 in preventing
brain tumor phenotypes caused by the formation of ectopic NSCs due
to the loss of Numb function, a process that may resemble brain tumor
formation from a subpopulation of CSCs in mammals. We
demonstrate that overexpression of dp53 abolishes ectopic neuroblast
formation in either numb mutant or animals overexpressing Numb-
TS4D, a recently genetically engineered dominant-negative form of
Numb [15]. At the mechanistic level, we show that the rescuing effect
of dp53 is largely mediated by Cyc E, rather than Dap/p21, and that
dp53 likely acts through the recently identified p53 target Ago to
influence Cyc E. Our results underscore an intimate relationship
between cell cycle progression and stem cell homeostasis and suggest
that manipulating levels of cell cycle regulators such as Cyc E and Ago
that can delay the cell cycle without stopping it might be therapeutically
beneficial for the targeting of CSCs.
Our results indicate that dp53 acts through the Ago/Cyc E axis
to regulate NSC homeostasis. Several lines of evidence are
consistent with this conclusion. Firstly, we provide evidence that
suppression of ectopic neuroblast formation by dp53 in numb
mutant and Numb-TS4D-overexpression background is not due
to induction of apoptosis in neuroblasts. A non-apoptotic role for
dp53 in causing cellular differentiation defects has previously been
observed in the fly eye [44]. Secondly, we demonstrate that the
rescuing effect of dp53 is unlikely mediated by Dap, the only
Drosophila homologue of members of the p21/p27 family in
vertebrates that are transcriptionally regulated by p53 and act as
inhibitors of CDKs to induce cellular senescence. Although there
are evidences in mammalian systems that implicate p21/p27
family members in NSC self-renewal or maintenance control
[17,18,19,45], in Drosophila larval brain the effect of dp53 on
ectopic neuroblast self-renewal in the numb mutant was apparently
not dependent on the function of Dap. A previous study has shown
that dp53 can interact with Dap/p21 to inhibit photoreceptor and
cone cell differentiation in the fly eye [44], suggesting that the
dp53-Dap axis might be functional in Drosophila, but it appears to
be deployed differently in different developmental contexts.
Considering the fact that overexpression of dp53 arrests
Figure 4. The inhibitory effect of dp53 on ectopic neuroblast formation is mediated through Cyc E. (A, B) The incorporation of Edu (red)
into dp53-expressing numb mutant neuroblasts is drastically reduced compared to numb mutant neuroblasts without dp53 overexpression. Clones
are marked with GFP (green), and cells with Edu labeling are indicated with arrows. The genotypes are FRT40A, numb
15 (A), and FRT40A, numb
15, UAS-
dp53-WT (B). (C–E) Overexpression of Cyc E (D, D’) or AgoDF( E, E’) is able to block the rescuing effect of dp53 on ectopic neuroblast formation in
numb mutant (C, C’). Clones are marked with GFP (green). Canonical neuroblasts identified as Dpn
+ cells (red) with a diameter of around 10 mm are
labeled with asterisks. The smaller Dpn
+ cells are intermediate progenitors. The genotypes of each panel are FRT40A, numb
15, UAS-dp53-WT (C),
FRT40A, numb
15, UAS-dp53-WT; UAS-Cyc E (D), and FRT40A, numb
15, UAS-dp53-WT; UAS-AgoDF (E), respectively. The differences in the number of
neuroblasts in these genetic backgrounds, 2.6760.52 (C, n=7), 13.2960.76 (D, n=7), and 9.4360.79 (E, n=7), are statistically significant (p,0.01 in
Student’s t-test). (F–G) Overexpression of Ago-WT (G, G’) is able to rescue the ectopic neuroblast phenotype of numb mutant (F, F’). Clones were
induced 48 hours ALH, different from 24 hours ALH induction shown in the other panels, and are marked with GFP (green). Mira
+ (blue) Ase
2 (red)
cells representing type II neuroblasts are labeled with asterisks. The genotypes of each panel are FRT40A, numb
15(F) and FRT40A, numb
15; UAS-Ago-WT
(G). The difference in the number of neuroblasts between these two genetic backgrounds, 10.560.76 (F, n=8) and 6.7560.46 (G, n=8), is statistically
significant (p,0.01 in Student’s t-test). Scale bars, 10 mm.
doi:10.1371/journal.pone.0028098.g004
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cycle regulators such as Cyc E, which is critical for G1-S
transition. In support of this notion, Cyc E level is reduced when
dp53 is overexpressed and exogenous expression of Cyc E reversed
the effect of dp53 in restraining ectopic neuroblast formation in
numb mutant. Thirdly, our genetic interaction studies using Ago, a
recently identified transcriptional target of p53 and a negatively
regulator of Cyc E, also support the notion that Cyc E is a key
downstream effector that mediates p53 function in NSC
homeostasis control.
Interestingly, the Ago/Cyc E pathway instead of Dap/p21 was
recently shown to be responsible for the activation of G1-S
checkpoint in the Drosophila eye disc in response to metabolic stress
[51,53], suggesting that the involvement of the Ago/Cyc E
pathway in mediating p53 function on the cell cycle may be more
pronounced under pathophysiological conditions. Consistent with
this notion, complete loss of p53 has no obvious effect on
neuroblast homeostasis under normal conditions or in partial loss
of Numb function background. However, it is possible that under
certain unique stressful or damaging conditions that affect NSC
proliferation or self-renewal vs. differentiation balance, the dp53
pathway would be activated to help maintain NSC homeostasis.
Inactivation of dp53 under those conditions might compromise the
homeostatic response, resulting in ectopic NSC self-renewal. This
would be analogous to the observation that double-stranded
breaks in DNA generated by the topoisomerase Spo11 during
recombination provoked functional p53 activity, which was
prolonged in cells defective for meiotic DNA repair [54]. This
would also be analogous to the requirement of dp53-dependent
mechanism in coordinating tissue growth in the developing wing
primordium of Drosophila, in which slowed growth due to
developmental or environmental stress in one compartment results
in reduced growth and proliferation rates in adjacent cells, even
though complete loss of dp53 under normal physiological
conditions has no effect on the growth or proliferation of wing
primordium cells [55]. Similarly, a critical role for dp53 in
compensatory proliferation in Drosophila imaginal discs was
revealed after tissue damage [56]. These studies support the
notion that the diverse functions of p53 are better studied under
stress or pathophysiological conditions.
Accumulating evidence supports the view that Cyc E is a
limiting factor for the G1-S transition during the cell cycle. Cyc E
was identified based on its ability to promote entry into S phase by
direct activation of CDK2. The effects of Cyc E on cell cycle
progression and cellular differentiation can be modified by its
interactions with diverse components, leading to different
outcomes in different cellular contexts [57,58,59]. For example,
in terminally differentiated cells like the Drosophila wing and eye
imaginal discs, simultaneous overexpression of Cyc E and E2F
could bypass cell-cycle exit after differentiation and enable cell-
cycle reentry [57]. This result suggests that preventing Cyc E-E2F
from aberrant activation in terminally differentiated tissues would
be critical for tissue homeostasis. In this study, exogenous
expression of Cyc E alone was sufficient to bypass dp53-induced
cell-cycle arrest in numb mutant and promote ectopic NSC
formation. Overexpression of Cyc E in mammalian systems also
drastically increased the efficiency of reprogramming from
differentiated somatic cells to iPSCs by Oct4, Sox2, Klf4, and c-
Myc [26]. It is possible that under these conditions, endogenous
levels of E2F are high enough to facilitate Cyc E action, or that
Cyc E can interact with other factors to achieve the same effect.
Previous studies in mammals have suggested that lengthening the
G1 phase is sufficient to switch neuroprogenitors from proliferative
to differentiative divisions during mouse early embryonic devel-
opment [60]. Thus, we propose that by downregulating Cyc E and
therefore lengthening the G1 phase of the cell cycle, overexpres-
sion of dp53 promotes the differentiation of NSCs and/or
intermediate progenitors in the neuroblast lineages, leading to a
reduction of the number of ectopic NSCs.
Formation of ectopic NSC due to unrestrained self-renewal is
likely to be a complex process involving cell cycle progression as
well as other processes such as cell growth, maintenance of
undifferentiated state, and possibly stress response and genomic
stability [61]. The components of the genetic program that control
stem cell self-renewal have not been fully identified in any system.
Our results suggest cell cycle control mediated by the p53/Ago/
Cyc E pathway is one important and necessary component of the
ectopic NSC self-renewal process, since disruption of this pathway
has clear consequence on ectopic NB formation in numb mutant
background. However, the p53/Ago/Cyc E pathway is clearly not
the whole story, since loss of p53 or overexpression of Cyc E in an
otherwise wild type background has no effect on normal NSC self-
renewal. Other processes are clearly implicated by our study
(Figure 5). Identifying the other critical factors that act together
with Cyc E in the NSC self-renewal process will be an interesting
future direction.
The dp53-mediated regulation of Cyc E through Ago in
Drosophila NSCs revealed in this study may have important
implications for understanding brain tumorigenesis in vertebrates.
Loss of p53 function is frequently observed in a subset of
glioblastoma that are known to contain CSCs [29,30,31,32,35].
Loss of Ago activity is also found in human tumor samples that
contain CSCs [37,38,62]. The cancer stem cell hypothesis was
initially developed in mammalian systems, where various studies
support the notion that CSCs share functional features with
normal stem cells, such as signaling molecules, pathways and
mechanisms governing their self-renewal vs. differentiation choice.
It remains poorly understood the cellular origin of CSCs and the
molecular and cellular mechanisms underlying their development
Figure 5. A diagram depicting the roles of Cyc E and other yet
to be identified factors involved in the ectopic neuroblast
formation process. A number of cellular processes such as cell cycle
progression regulated by Cyc E and other processes mediated by
unknown factors X, Y, Z are proposed to act coordinately to promote
the self-renewal of normal or cancer stem cells. Interruption of any one
of these processes, as in the case of inhibition of Cyc E expression
through Ago by p53, will disrupt the self-renewal process. On the other
hand, to promote ectopic neuroblast self-renewal, Cyc E and the other
factors (X, Y, Z) would all have to be upregulated in a coordinated
fashion. Activation of Cyc E alone will not be sufficient.
doi:10.1371/journal.pone.0028098.g005
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expansion of normal stem cell niches, 2) normal stem cells adopting to
different niches, 3) normal stem cell becoming niche-independent, or 4)
differentiated progenitor cells [63]. In the Drosophila larval brain, CSCs
can arise from the dedifferentiation of transit-amplifying progenitor
cells back to stem cell-like state [64,65]. Importantly, our study has
identified the p53/Ago/Cyc E pathway as a critical axis involved in
this dedifferentiation process. This dedifferentiation process may share
certain similarity to reprogramming involved the production of iPSCs
in mammals, which also involves p53 [50]. We speculate that elevated
levels of Cyc E due to inactivation of p53 or Ago under
pathophysiological conditions could have detrimental consequences
on tissue homeostasis due to aberrant CSC behavior. It would be
interesting to examine whether the p53-Ago-Cyc E signaling pathway
characterized in this study may also play a pathological role in brain
tumorigenesis in vertebrates.
Materials and Methods
Fly genetics
All the fly stocks and GAL4 lines were obtained from the
Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center
(VDRC), or previously described in the literature. The following flies
were used in this study: UAS-dp53-WT, UAS-dp53-H159N, UAS-APC2
RNAi, numb
15 [66], UAS-AgoWT, UAS-AgoDF [67], UAS-dp53 RNAi (a
gift of Dr. Andreas Bergmann), and FRT42D, dap/cyo [57].
To generate single neuroblast clones in MARCM analysis,
virgin females of yw hsflp; FRT40A, GAL80; tubulin-GAL4, UAS-
mCD8-GFP were crossed to males of FRT40A, numb
15 without or
with the corresponding transgenes shown in each panel, and the
larval progenies were heat-shocked at 37uC for 90 minutes,
24 hours ALH (after larval hatching) or 48 hours ALH, and
further aged for 3 days at 25uC before analysis.
Immunohistochemistry
Larval brain tissues were fixed in 4% formaldehyde according
to standard procedures [11]. The primary antibodies used were:
rabbit anti-Asense (1:1000), rat anti-CycE (1:100), guinea pig anti-
Deadpan (1:1000), chicken anti-GFP (1:3000), mouse anti-p-
Histone3 (1:1000), rabbit anti-Miranda (1:1000), mouse anti-
Myc4A6 (1:500), and guinea pig anti-Numb (1:1000). Quantifica-
tion of neuroblast numbers was done at 96 hrs ALH at 25uC.
Larvae of each genotype were dissected and stained with
neuroblast marker Miranda or Deadpan. Central brain neuro-
blasts can be distinguished from optic lobe neuroblasts based on
their medial-superficial location, larger size and dispersed pattern.
Western blotting
Third instar larvae overexpressing UAS transgenes of dp53-WT,
Ago-WT with heat shock (hs)-GAL4 driver were heat shocked at
37uC for 60 minutes and transferred to 25uC incubators for
10 hours. Then extracts were prepared from dissected larval
brains and subjected to SDS-PAGE. The endogenous Cyc E levels
were detected by rat anti-Cyc E antibody (a gift of Dr. Helena
Richardson). Actin serves as loading control.
TUNEL assay
ApopTagH direct fluorescein in situ apoptosis detection kit
(Millipore) was used to detect apoptotic cells in larval brain in
accordance with manufacturer’s instructions.
Neuroblast labeling with EdU and EdU detection
The Click-iTH EdU Alexa FluorH 594 kit (Invitrogen) was used
to assess neuroblast proliferation. In brief, the dissected larval
brain was incubated with 10 mM EdU in Schneider’s insect
medium for 30 min. The tissues were further processed by fixation
in 4% formaldehyde according to standard procedures. Incorpo-
rated EdU was detected by Alex Fluor 594 azide in accordance
with manufacturer’s instructions.
Supporting Information
Figure S1 Testing the effect of loss of dp53 on ectopic
neuroblast formation induced by Numb loss of function.
Larval brain neuroblasts of 1407-Gal4.NumbS2D (A), 1407-
Gal4.Numb-S2D; dp53 (B), and dp53 (C) animals were stained
with Miranda (Mira). The dashed lines separate central brain
neuroblasts (left) from optic lobe neuroblasts (right). Bar graph
shows quantification of central brain neuroblast numbers in the
different genotypes.
(TIF)
Figure S2 Overexpression of the apoptosis inhibitor p35
has no effect on normal neuroblast number. Larval brain
neuroblasts of wild type (A) and 1407-Gal4.UAS-p35 (B) animals
were stained with Miranda (Mira). The dashed lines separate
central brain neuroblasts (left) from optic lobe neuroblasts (right).
(C) Bar graph shows quantification of central brain neuroblast
numbers in the two genotypes.
(TIF)
Figure S3 Loss of dap has no effect on type II neuroblast
self-renewal. GFP-marked wild type (A, A’) and dap mutant (B,
B’) neuroblast MARCM clones were stained for Asense (red),
GFP (green), and Mira (blue). Type II neuroblasts are Asense-
Mira+. In both wild type and dap mutant clones, there is one and
only one neuroblast/clone.
(TIF)
Figure S4 dp53 overexpression leads to downregulation
of Cyc E protein levels. Reprehensive type II NB lineages in
WT or 1407.UAS-dp53 backgrounds were circled with dashed
lines. Type II NBs: yellow bracket; type I NBs: white bracket. Bar
graph shows quantification of Cyc E levels in type II NBs. The
difference between the two genotypes is significant (p,0.0001 in
Student’s t test, n=11). Only NBs at interphase of the cell cycle
were quantified.
(TIF)
Figure S5 Control experiments showing that overex-
pression of Cyc E or Ago in an otherwise wild type
background does not affect larval brain neuroblast
number. (A) wild type and 1407-Gal4.UAS-Cyc E larval brains
were stained for the neuroblast marker Dpn and differentiation
marker Prospero. No difference was observed. (B) wild type and
1407-Gal4.UAS-Ago-WT larval brains were stained for the
neuroblast marker Dpn and differentiation marker Prospero. No
difference was observed.
(TIF)
Figure S6 Western blot analysis showing negative
regulation of Cyc E protein levels by dp53 and Ago.
Control wild type (w-) animals or UAS transgenic animals
overexpressing dp53 or Ago were crossed to hs-Gal4 flies. Resulting
third instar larvae were subjected to heat shock and recovery
treatments and larval brain tissues were subsequently dissected out
for extract preparation. Brain extracts were subjected to Western
blot analysis of Cyc E and actin levels.
(TIF)
Figure S7 Testing the effect of loss of one copy of ago on
ectopic neuroblast formation induced by Numb-TS4D.
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Gal4.Numb-TS4D; ago+/2 (B) animals were stained for the neuroblast
marker Dpn and differentiation marker Prospero. The dashed lines
separate central brain neuroblasts (right) from optic lobe neuroblasts
(left). No difference was observed between the two genotypes.
(TIF)
Figure S8 Testing the effect of AgoDF or Cyc E
overexpression on the neuroblast-loss phenotypes
caused by dp53 or Numb overexpression. Top panels:
Larval brain neuroblasts of 1407-Gal4.UAS-dp53 (A), 1407-
Gal4.UAS-dp53; UAS-Cyc E (B), and 1407-Gal4.UAS-dp53;
UAS-AgoDF (C) animals were stained for Miranda (Mira). The
dashed lines separate central brain neuroblasts (left) from optic
lobe neuroblasts (right). Bar graph shows quantification of
neuroblast numbers in the different genotypes. AgoDF and Cyc
E both showed partial rescue of the neuroblast-loss induced by
dp53. Bottom panels: Larval brain neuroblasts of 1407-
Gal4.UAS-Numb (D) and 1407-Gal4.UAS-Numb; UAS-AgoDF (E)
animals were stained for Miranda (Mira). The dashed lines
separate central brain neuroblasts (left) from optic lobe neuroblasts
(right). Numb overexpression led to complete loss of the 8 type II
neuroblasts/brain lobe, which are identifiable based on their
stereotypic position and lineage composition. This phenotype was
not rescued by the co-expression of AgoDF.
(TIF)
Figure S9 Effect of dp53 overexpression on dMyc
protein level. Top panels: Reprehensive immunostaining images
of wild type and 1407-Gal4.UAS-dp53 whole brain tissues stained
for F-actin (green), dMyc (red), and Pros (blue). Arrowheads point
to neuroblasts that are shown at higher magnification in the
bottom panels. Bottom panel: Select neuroblasts of the two
genotypes shown at higher magnification. Bar graph shows
quantification of dMyc levels in the two genotypes. No significant
difference was detected.
(TIF)
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